ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
作者信息
van der Ven Roos G F M, van den Heuvel Teun B M, Rovers Koen P B, Nienhuijs Simon W, van Erning Felice N, de Hingh Ignace H J T
机构信息
Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Department of Health Services Research, Faculty of Health, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
出版信息
Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.
Abstract
摘要
相似文献
1
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.
2
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
Ann Surg Oncol. 2024 Jun;31(6):3758-3768. doi: 10.1245/s10434-024-15131-0. Epub 2024 Mar 7.
3
Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
Eur J Surg Oncol. 2021 Nov;47(11):2865-2872. doi: 10.1016/j.ejso.2021.05.046. Epub 2021 Jun 3.
4
High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.
BMC Cancer. 2021 Jan 7;21(1):41. doi: 10.1186/s12885-020-07756-7.
5
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.
J Surg Oncol. 2022 Mar;125(4):703-711. doi: 10.1002/jso.26759. Epub 2021 Nov 29.
6
Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol. 2018 Jul;25(7):1992-2001. doi: 10.1245/s10434-018-6423-8. Epub 2018 Apr 18.
7
Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
Ann Surg Oncol. 2019 May;26(5):1445-1453. doi: 10.1245/s10434-019-07218-w. Epub 2019 Mar 1.
8
ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.
9
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
Asian J Surg. 2021 Jan;44(1):221-228. doi: 10.1016/j.asjsur.2020.05.010. Epub 2020 Jun 27.
10
Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.
Ann Surg Oncol. 2024 Sep;31(9):6220-6227. doi: 10.1245/s10434-024-15180-5. Epub 2024 Mar 28.
本文引用的文献
1
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
Ann Surg Oncol. 2024 Jun;31(6):3758-3768. doi: 10.1245/s10434-024-15131-0. Epub 2024 Mar 7.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Eur J Surg Oncol. 2021 May;47(5):1026-1033. doi: 10.1016/j.ejso.2020.11.135. Epub 2020 Nov 26.
4
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts.
Clin Colorectal Cancer. 2020 Dec;19(4):277-284. doi: 10.1016/j.clcc.2020.06.010. Epub 2020 Jul 15.
5
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.
Eur J Cancer. 2017 Apr;75:132-140. doi: 10.1016/j.ejca.2016.12.034. Epub 2017 Feb 20.
Zotero 插件